Press Release: Lyell Immunopharma to Acquire ImmPACT Bio and Prioritizes Its Pipeline to Focus on Next-Generation CAR T-cell Therapies
Why Deckers Outdoor Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
12 Health Care Stocks Moving In Thursday's After-Market Session
Lyell Immunopharma: Cash Runway Following the Close of the Transaction Is Expected to Fund Ops Into 2027 >LYEL
Express News | Lyell Immunopharma Inc: Initiating a Pivotal Trial for Impt-314 in 2025
Express News | Lyell Immunopharma Inc - Deal Includes $30 Million Cash and 37.5 Million Lyell Shares
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}